Revealed: Our 'Shadow Investing' Secret for Small Cap Stocks
Here is the latest financial fact sheet of EVOQ REMEDIES LTD.. For more details, see the EVOQ REMEDIES LTD. quarterly results and EVOQ REMEDIES LTD. share price. For a sector overview, read our finance sector report.
1 Day | % | -0.6 |
No. of shares | m | 13.60 |
1 Week | % | -3.3 |
1 Month | % | -3.4 |
1 Year | % | -24.4 |
52 week H/L | Rs | 19.4/8.5 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
EVOQ REMEDIES LTD. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 25 | 24 | |
Low | Rs | NA | NA | NA | 23 | 11 | |
Sales per share (Unadj.) | Rs | 3,250.0 | 9,072.0 | 10,025.0 | 12.3 | 15.0 | |
Earnings per share (Unadj.) | Rs | 11.0 | 0 | 715.0 | 0.8 | 1.2 | |
Diluted earnings per share | Rs | 0.0 | 0.0 | 0.5 | 0.8 | 1.2 | |
Cash flow per share (Unadj.) | Rs | 11.0 | 0 | 715.0 | 0.8 | 1.2 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 22.0 | 23.0 | 743.0 | 17.0 | 18.2 | |
Adj. book value per share | Rs | 0.0 | 0.0 | 0.5 | 17.0 | 18.2 | |
Shares outstanding (eoy) | m | 0.01 | 0.01 | 0.01 | 13.60 | 13.60 | |
Price / Sales ratio | x | 0 | 0 | 0 | 1.9 | 1.2 | |
Avg P/E ratio | x | 0 | 0 | 0 | 29.7 | 14.9 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 29.7 | 14.9 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 1.4 | 1.0 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 324 | 241 | |
Total wages/salary | Rs m | 0 | 0 | 0 | 2 | 2 |
EVOQ REMEDIES LTD. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 33 | 91 | 100 | 168 | 204 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 60 | |
Total revenues | Rs m | 33 | 91 | 100 | 168 | 264 | |
Gross profit | Rs m | 0 | 0 | 10 | 15 | -37 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | 0 | 0 | 10 | 15 | 23 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 2 | 4 | 7 | |
Profit after tax | Rs m | 0 | 0 | 7 | 11 | 16 | |
Gross profit margin | % | 0.5 | 0 | 9.5 | 8.7 | -18.3 | |
Effective tax rate | % | 30.6 | 20.0 | 25.0 | 25.2 | 29.1 | |
Net profit margin | % | 0.3 | 0 | 7.1 | 6.5 | 7.9 |
EVOQ REMEDIES LTD. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 21 | 57 | 80 | 333 | 349 | |
Current liabilities | Rs m | 21 | 56 | 73 | 102 | 101 | |
Net working cap to sales | % | 0.7 | 0.3 | 7.4 | 138.0 | 121.5 | |
Current ratio | x | 1.0 | 1.0 | 1.1 | 3.3 | 3.4 | |
Inventory Days | Days | 0 | 0 | 0 | 0 | 0 | |
Debtors Days | Days | 1,379 | 1,898 | 248,894,851 | 5,523 | 3,082 | |
Net fixed assets | Rs m | 0 | 0 | 0 | 0 | 0 | |
Share capital | Rs m | 0 | 0 | 0 | 136 | 136 | |
"Free" reserves | Rs m | 0 | 0 | 7 | 96 | 112 | |
Net worth | Rs m | 0 | 0 | 7 | 232 | 248 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 21 | 57 | 80 | 333 | 349 | |
Interest coverage | x | 0 | 0 | 0 | 292.6 | 2,286.0 | |
Debt to equity ratio | x | 0 | 0.3 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.5 | 1.6 | 1.2 | 0.5 | 0.6 | |
Return on assets | % | 0.5 | 0 | 8.9 | 3.3 | 4.6 | |
Return on equity | % | 50.5 | 1.3 | 96.3 | 4.7 | 6.5 | |
Return on capital | % | 67.5 | 2.4 | 128.2 | 6.3 | 9.2 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
EVOQ REMEDIES LTD. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 0 | -0 | 0 | -264 | -43 | |
From Investments | Rs m | 0 | 0 | 0 | 0 | -0 | |
From Financial Activity | Rs m | 0 | 0 | 0 | 295 | 14 | |
Net Cashflow | Rs m | 0 | -0 | 0 | 31 | -29 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Bhumishth Narendrabhai Patel | COMP SEC: Gitika Mishra | YEAR OF INC: 2010 | BSE CODE: 543500 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: BAJAJ FINANCE BAJAJ FINSERV SBI CARDS CHOLAMANDALAM INVEST BAJAJ HOLDINGS & INVESTMENT
Compare EVOQ REMEDIES LTD. With: BAJAJ FINANCE BAJAJ FINSERV SBI CARDS CHOLAMANDALAM INVEST BAJAJ HOLDINGS & INVESTMENT
Indian share markets ended the mock trading session on a positive note tracking strong global peers and FII inflows.